HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists?

Similar Items

• GLP-1 receptor agonists and cardiovascular outcome trials: An update
  by: Eirini Andrikou, et al.
  Published: (2019-11-01)
• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
  by: Kristensen, SL, et al.
  Published: (2019)
• An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors
  by: Mustafa Kılıçkap, et al.
  Published: (2021-02-01)
• Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis
  by: Jinjing Wei, et al.
  Published: (2022-12-01)
• GLP-1 Receptor Agonists and Kidney Protection
  by: Eulalia Valentina Greco, et al.
  Published: (2019-05-01)